Zimmer Biomet Holdings Non Us — PP&E (Net) increased by 10.8% to $875.60M in Q4 2025 compared to the prior quarter.
An increase often signals capital investment in international manufacturing capacity or infrastructure, whereas a decrease may indicate asset divestiture, high depreciation rates, or a shift toward outsourced production models.
This metric reflects the net book value of tangible long-term assets, such as manufacturing facilities, distribution cen...
Global medical device manufacturers often compare this metric against international revenue to assess the capital intensity and operational efficiency of their foreign segments.
zbh_segment_non_us_property_plant_and_equipment_net| Q4 '24 | Q4 '25 | |
|---|---|---|
| Value | $790.50M | $875.60M |
| QoQ Change | — | +10.8% |
| YoY Change | — | +10.8% |